The fda asked the maker of weight-loss drug belviq (lorcaserin) to take it off the market after a clinical trial showed an association with an increased risk of cancer. Belviq medication. The risk and safety of belviq when used with other drugs that affect serotonin hasn't been evaluated yet, but the label contains a warning to "use extreme caution" when administering belviq with ssris, snris, tcas, wellbutrin, maois, antipsychotics, lithium, and st john's wort .
belviq medication
Drugscom provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products this material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment data sources include ibm watson micromedex (updated 10 aug 2020), cerner multum™ (updated 3 aug 2020), wolters kluwer™ (updated. Does belviq interact with other medications? find lowest prices. read more. overdose. overdose. if someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Lorcaserin, marketed under the brand name belviq is a weight-loss drug developed by arena pharmaceuticals.it reduces appetite by activating a type of serotonin receptor known as the 5-ht 2c receptor in a region of the brain called the hypothalamus, which is known to control appetite. it was removed from the market in the united states in 2020 due to its increased risk of cancer..
Comments
Post a Comment